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Abstract
Two variants of the cytochrome c1 component of the Rhodobacter capsulatus cytochrome bc1 complex, in which Met
183 (an axial heme
ligand) was replaced by lysine (M183K) or histidine (M183H), have been analyzed. Electron paramagnetic resonance (EPR) and magnetic
circular dichroism (MCD) spectra of the intact complex indicate that the histidine/methionine heme ligation of the wild-type cytochrome is
replaced by histidine/lysine ligation in M183K and histidine/histidine ligation in M183H. Variable amounts of histidine/histidine axial heme
ligation were also detected in purified wild-type cytochrome c1 and its M183K variant, suggesting that a histidine outside the CSACH heme-
binding domain can be recruited as an alternative ligand. Oxidation–reduction titrations of the heme in purified cytochrome c1 revealed
multiple redox forms. Titrations of the purified cytochrome carried out in the oxidative or reductive direction differ. In contrast, titrations of
cytochrome c1 in the intact bc1 complex and in a subcomplex missing the Rieske iron–sulfur protein were fully reversible. An Em7 value of
 330 mV was measured for the single disulfide bond in cytochrome c1. The origins of heme redox heterogeneity, and of the differences
between reductive and oxidative heme titrations, are discussed in terms of conformational changes and the role of the disulfide in maintaining
the native structure of cytochrome c1.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The cytochrome bc1 complex (ubihydroquinone:cyto-
chrome c oxidoreductase) is found in a wide variety of
prokaryotes and eukaryotes. This integral membrane protein
complex contributes to the formation of the electrochemical
proton gradient, required for endergonic processes such as
ATP formation and active transport, during both respiratory
and photosynthetic electron transfer [1–5]. In anoxygenic
photosynthetic prokaryotes, the cytochrome bc1 complex is
located in the cytoplasmic membrane and contains only
three or four subunits [2], in contrast to the 10 or more
subunits found in the corresponding mitochondrial com-
plexes [4]. In all cases, the cytochrome bc1 complex (and
the functionally homologous cytochrome b6 f complex of
oxygenic photosynthetic organisms [6]) contains only three
subunits with redox-active centers. The cytochrome c1
subunit contains a single, covalently bound c-type heme,
and the Rieske iron–sulfur protein subunit contains a single
[2Fe–2S] cluster. The cytochrome b subunit contains two
chemically equivalent, noncovalently bound protohemes,
but different local environments cause the two hemes
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(usually designated as bH and bL) to have different absorb-
ance spectra and Em values [1–5]. The heme of the
cytochrome c1 subunit is the point of exit for electrons
traversing the cytochrome bc1 complex. In mitochondria
and aerobic prokaryotes, cytochrome c1 serves as the direct
electron donor to acceptors such as the mobile, soluble
protein, cytochrome c [1,3–5]. In anoxygenic photosyn-
thetic bacteria, cytochrome c1 serves as the direct reductant
for soluble electron transfer proteins such as cytochrome c2,
cytochrome c8 and high potential iron–sulfur protein
(HiPIP), and the membrane-bound cytochrome cy [2,7–17].
In anoxygenic photosynthetic prokaryotes, the three
redox-active subunits are encoded by three genes organized
in an operon, called either fbc or pet [2]. A comparison of
the translated gene sequences of petA (encoding the Rieske
iron–sulfur protein), petB (encoding cytochrome b) and
petC (encoding cytochrome c1) with the sequences of the
mature proteins indicates that only cytochrome c1 has an N-
terminal signal sequence that is cleaved posttranslationally
[2]. Covalent attachment of the heme to two cysteine
residues at the heme-binding domain of apocytochrome c1
occurs in the periplasmic space of the bacterium after
transport across the cytoplasmic membrane and cleavage
of the signal sequence [18].
Previous electron paramagnetic resonance (EPR) and
near-IR magnetic circular dichroism (MCD) spectroscopic
studies in our laboratories on cytochrome bc1 complexes,
isolated from bovine mitochondria and from three photo-
synthetic purple nonsulfur bacteria, established that the two
axial ligands to the heme iron of cytochrome c1 are histidine
and methionine [19]. In the case of mitochondrial cyto-
chrome c1 (from beef, chicken and yeast mitochondria), this
spectroscopic assignment of axial ligands has been con-
firmed by X-ray crystallography [20–22]. Site-directed
mutagenesis studies, carried out on the cytochrome bc1
complex of the purple nonsulfur bacterium Rhodobacter
capsulatus [23], identified M183 as the methionine that
serves as an axial heme ligand in the wild-type cytochrome
(the numbering system used throughout is based on sequence
positions in the mature form of cytochrome c1). A surprising
finding of this earlier study was that Rb. capsulatus cyto-
chrome c1 containing a M183L mutation was primarily a
low-spin, six-coordinate species, despite the fact that the
leucine inserted at position 183 could not serve as a ligand to
the heme iron [23]. EPR and near-IR MCDmeasurements on
the M183L variant were consistent with a cytochrome
containing two histidine axial ligands [19]. It was also shown
that under certain conditions, wild-type Rb. capsulatus
cytochrome c1 could undergo partial re-folding to a low-spin
form with two nitrogen (very likely bis-histidyl) axial ligands
[19]. In order to further explore the possibility that Rb.
capsulatus cytochrome c1 can exhibit significant structural
flexibility and can refold to recruit an amino acid other than
M183 as an axial ligand, we have undertaken detailed
electrochemical and spectroscopic characterization of the
M183K and M183H variants of cytochrome c1.
While cytochrome c1 no doubt functions in a relatively
fixed conformation when it is part of the cytochrome bc1
complex in vivo, the flexibility of cytochrome c1 docu-
mented in the results presented below provides insight into
how different protein conformations affect the redox proper-
ties of its heme. Moreover, this study expands and comple-
ments the published characterization of the phenotypes of
cells containing these variants and the optical absorption
and oxidation–reduction properties of cytochrome bc1 com-
plexes containing these variants of cytochrome c1 [24].
Further investigation of possible conformational plasticity
in Rb. capsulatus cytochrome c1 is warranted because this
cytochrome appears to have several distinguishing charac-
teristics not present in other members of the cytochrome c
family. In particular, the redox properties of its heme appear
to be controlled through a recently discovered disulfide that
anchors a loop immediately preceding the M183 axial heme
ligand [25]. For this reason, the investigations of the redox
properties of Rb. capsulatus cytochrome c1 were extended
to include redox titrations of this disulfide bond.
2. Materials and methods
Rb. capsulatus cells containing the wild-type cytochrome
bc1 complex, or a cytochrome bc1 complex containing either
the M183K or M183H mutation in cytochrome c1, were
grown as described previously [24,26]. Wild-type and
mutated cytochrome bc1 complexes were solubilized, puri-
fied and checked for purity as described previously [24,27].
A two-subunit cytochrome bc1 subcomplex, missing the
Rieske iron–sulfur subunit, was prepared as described
previously [28,29]. Aliquots (0.5 to 1.0 ml) of purified
complex and subcomplex were stored at  80 jC in 100
mM Tris–HCl buffer (pH 8.0) containing 50 mM NaCl and
0.1 mg/ml dodecyl maltoside.
The cytochrome c1 component of the wild-type and
mutated cytochrome bc1 complexes was prepared, using
purified cytochrome bc1 complexes as the starting material,
by a modification of previously used procedures [23,30].
Solutions containing the cytochrome bc1 complex were
made 10% (v/v) in glycerol and were then precipitated by
the addition of ammonium sulfate (80% saturation). The
precipitate was collected by centrifugation at 30,000 rpm for
30 min in a Beckman Ti 70 rotor at 2 jC and resuspended in
1–2 ml of Buffer A [25 mM Tris–HCl buffer (pH 8.0)
containing 1 mM DTT and 1 mM EDTA] containing 0.25%
(w/v) sodium cholate. After an overnight incubation at 4 jC,
the mixture was applied to a column (1.5 10 cm) contain-
ing Phenyl Sepharose CL-4B (Pharmacia Biotech) pre-
equilibrated with the same buffer used for the overnight
incubation. The column was washed with this buffer and
then eluted, in a stepwise fashion, with 50 ml of Buffer A
containing 2% sodium cholate, then with 10 ml of Buffer A
containing 2% sodium cholate and 1.5 M guanidine–HCl,
and finally with 100 ml of Buffer A containing 2% sodium
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cholate. Fractions enriched in cytochrome c1 were concen-
trated (to a final volume of approximately 0.5 ml) and buffer
exchange (to Buffer A containing 10 mM NaCl and 0.01%
dodecyl maltoside) was carried out under a nitrogen atmos-
phere, using an Amicon concentrator with a molecular
weight cutoff of 10 kDa. The sample was loaded onto a
Pharmacia Superdex 75 HR10/30 column pre-equilibrated
with Buffer A containing 10 mM NaCl and 0.01% dodecyl
maltoside. Elution, with this same buffer, was carried out
using a Pharmacia/LKB FPLC system at a flow rate of 0.4
ml/min. For those experiments designed to test the effect of
a disulfide on the redox properties of the purified, wild-type
cytochrome c1, DTT was omitted from all buffers, but the
other conditions were left unchanged. Fractions were ana-
lyzed for purity by reduced minus oxidized difference
spectra and SDS-PAGE (electrophoresis was carried out
using a Pharmacia PhastGel system). Cytochrome c1-con-
taining fractions were pooled and concentrated. These
samples contained no detectable cytochrome b but usually
contained varying, small amounts of the Rieske iron–sulfur
protein. Analysis of SDS-PAGE gels stained with Coomas-
sie brilliant blue, using a Molecular Dynamics Model 300B
Computing Densitometer, indicated an average purity of
approximately 90% for the cytochrome c1 samples. Purifi-
cation of wild-type cytochrome c1 from the two-subunit
cytochrome bc1 subcomplex was carried out in a manner
similar to that described for that using the intact complex,
except that DTT was absent from the buffers and the step
involving FPLC chromatography on Superdex 75 HR10/30
was omitted. SDS-PAGE analysis of the cytochrome
showed no detectable impurities.
An Rb. capsulatus strain expressing a two-subunit bc1
subcomplex that has no disulfide bond was prepared as
follows: The 1.0-kb BstXI/SmaI fragment of plasmid pF:
H135L bearing the petABC operon with the H135L mutation
in the Rieske iron–sulfur protein subunit [31] was exchanged
with the corresponding fragment of the plasmid pC:C144A/
C167A carrying the double mutation C144A/C167A in the
cytochrome c1 subunit [25]. This plasmid, carrying the
H135L mutation in petA and the C144A/C167A mutations
in petC, named as pAO1, was conjugated into Rb. capsulatus
strain MT-RBC1 carrying the petABC deletion mutation [26]
via triparental crosses. The presence of the engineered
mutations was confirmed by sequencing of plasmid DNA
isolated from this strain. pAO1/MT-RBC1 lacks the Rieske
iron–sulfur protein subunit, due to the mutation H135L [31],
and overproduces a cytochrome bc1 subcomplex which is
devoid of any non-heme-binding cysteine residues, because
of the C144A and C167A mutations in the cytochrome c1
subunit [25] and the natural absence of any cysteine in the
cytochrome b subunit.
Absorbance spectra, reduced minus oxidized difference
spectra, and spectral change during oxidation–reduction
titrations were recorded using a Shimadzu Model UV-
2100U spectrophotometer at 1-nm spectral resolution. Sam-
ples used for EPR and variable-temperature, near-IR MCD
were oxidized with fivefold excess ferricyanide prior to
spectroscopic studies and the excess ferricyanide was sub-
sequently removed by Amicon ultrafiltration during
exchange from H2O to D2O buffering medium as required
for near-IR MCD studies. Treatment with ferricyanide
ensured that all cytochromes present were fully oxidized
and eliminated EPR signals from any reduced Rieske iron–
sulfur protein that might be present. Samples for variable-
temperature, near-IR MCD studies contained 55% d2-ethyl-
ene glycol or d3-glycerol to enable optical-quality glasses to
form on freezing. Near-IR and UV–visible MCD spectra
were recorded on Jasco J730 and J715 spectropolarimeters,
respectively, using 1-mm optical pathlength cuvettes. Vari-
able temperature (1.5–273 K) MCD measurements were
recorded with an applied field of 6 T using an Oxford
Instruments Spectromag 4000 split-coil superconducting
magnet mated to the spectropolarimeters. The experimental
protocols used in the MCD studies for accurate sample
temperature and magnetic field measurement, sample han-
dling and assessment of residual strain in frozen samples
have been described in detail elsewhere [32,33]. X-band
EPR studies on the MCD samples were carried out using a
Bruker ESP-300E spectrometer equipped with an Oxford
Instruments ESR-9 flow cryostat.
Redox titrations of the cytochrome c1 heme were carried
out as described by Dutton [34]; monitoring absorbance
changes in the a-band region. Cytochrome bc1 complex, or
the two-subunit bc1 subcomplex or purified cytochrome c1
(0.5 to 1 mg), was diluted to 8 ml with 50 mM MOPS (pH
7.0) containing 100 mM KCl and either 0.25% cholate or
0.01% dodecyl maltoside and the following redox media-
tors: either 20 AM PMS, 20 AM PES, 50 AM DAD and 25
AM 2-hydroxy-1,4-naphthoquinone, 1,4-naphthoquinone
and 1,2-naphthoquinone; or 25 AM 1,1V-dimethylferrocene,
1,4-benzoquinone, 1,2-naphthoquinone, PMS, PES, mena-
dione, 2-hydroxy-1,4-naphthoquinone and anthraquinone-2-
sulfonic acid. Reductive titrations were performed by first
oxidizing the sample to Eh= + 400 mV with potassium
ferricyanide and then reducing it stepwise with sodium
dithionite to Eh = 300 mV. For oxidative titrations, the
sample was first reduced to Eh = 350 mV with sodium
dithionite and then re-oxidized with potassium ferricyanide.
The Em values were determined by fitting the data to the
Nernst equation for a one-electron carrier (n = 1) with 1, 2 or
3 components, as needed.
Oxidation–reduction titrations of the disulfide bond in
cytochrome c1 were carried out using redox-poising at
defined Eh values, established by incubation in oxidation–
reduction buffers with varying ratios of reduced and oxidized
DTT, followed by labeling of cysteine thiols by the fluores-
cent reagent monobromobimane (mBBr), as described pre-
viously [35,36].Em values were determined by fitting the data
to the Nernst equation for a single two-electron carrier (n = 2).
The reported experimental uncertainties in Em values repre-
sent the standard deviations. Samples of the two-subunit bc1
subcomplex were dialyzed against either 100 mM Tricine
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buffer (pH 8.0) containing 0.01% dodecyl maltoside or 100
mMMOPS buffer (pH 7.0) containing 0.01% dodecyl malto-
side, before the titrations.
The N-terminal amino acid sequences of the M183K and
M183H mutated forms of cytochrome c1 were determined in
the Core Instrument Facility of the Texas Tech University
Center for Biotechnology and Genomics, using a Beckman/
Porton Model 2020 Protein Sequencer with an on-line
Beckman Gold HPLC system as described previously [19].
3. Results
Our initial characterization of the M183K and M183H
variants of Rb. capsulatus cytochrome c1 was carried out
using preparations of the intact cytochrome bc1 complex
that carried these mutations [24]. However, further charac-
terization of the effects of replacing the native methionine
axial ligand with two other potential ligands, histidine and
lysine, required purified samples of the mutated cytochrome
c1 (see below). The availability of the purified cytochromes
allowed determination of the N-terminal sequences of the
two mutated proteins. Identical N-terminal sequences of
NSNVPD were obtained for both the M183H and M183K
forms of cytochrome c1. As this sequence is identical to that
previously obtained for the wild-type cytochrome [19], it is
concluded that cleavage of the N-terminal signal sequence
of the pre-apocytochrome during cytochrome c biogenesis is
unaffected by the mutations.
The visible-region absorbance spectra of dithionite-
reduced samples of wild-type cytochrome c1 and its
M183H and M183K variants all exhibit Soret-band maxima
at 418 nm, a-band maxima at 552 nm and h-bands centered
at 522 nm (Fig. 1). The Soret bands of both variants show
small but reproducible shoulders on the long wavelength
side, suggesting the possibility that each variant contains
more than one cytochrome c species. While no well-defined
shoulder can be discerned in the Soret band of the wild-type
cytochrome, its breadth is consistent with the possible
presence of more than one species (See below for additional
evidence of heterogeneity). The a-band spectra support the
conclusion, when combined with the results of SDS-PAGE,
that these preparations are free of any contaminating cyto-
chrome b.
The combination of EPR and near-IR MCD in the
porphyrin-to-Fe charge-transfer region provides a powerful
methodology for assessing the axial ligation of low-spin
ferric hemoproteins [37–39]. Moreover, this approach has
proven effective even with multi-component cytochrome
systems, such as the cytochrome bc1 complex, when per-
formed under appropriate conditions [19]. In the case of Rb.
capsulatus cytochromes, EPR and near-IR MCD spectra of
the wild-type bc1 complex and purified cytochrome c1 are
already available for comparison to any spectra obtained for
the variant samples [19]. Hence, parallel EPR and near-IR
MCD studies were carried out to assess the heme axial
ligation in the M183K and M183H variants of Rb. capsu-
latus cytochrome c1, both in intact cytochrome bc1 com-
plexes and after purification of the cytochrome c1
polypeptides.
3.1. Spectroscopic properties of the M183K cytochrome c1
variant
The EPR spectrum of the intact bc1 complex with the
M183K cytochrome c1 mutation exhibits low-field features
from low spin Fe(III) heme components at g = 3.78, 3.44,
3.30 and 2.94 (Fig. 2A). The spectrum is very similar to that
observed for the wild-type Rb. capsulatus cytochrome bc1
complex [19], and is readily assigned based on the previous
studies. Thus, the g = 3.78 and 3.44 features are assigned to
cytochrome bL and cytochrome bH, respectively, and the
Fig. 1. Absorbance spectra of wild-type Rb. capsulatus cytochrome c1 and
its M183H and M183K variants. The reaction mixtures contained the wild-
type cytochrome (panel A), or the M183H variant (panel B), or the M183K
variant (panel C) at concentrations of 25.5, 6.3 and 18.5 AM, respectively,
in 25 mM Tris–HCl buffer (pH 8.0) containing 1 mM DTT, 1 mM EDTA,
10 mM NaCl and 0.01% dodecyl maltoside. The spectra shown in (A), (B)
and (C) were measured against a buffer blank with samples reduced by the
addition of a small amount of solid sodium dithionite. The optical
pathlength of the cuvette was 1.0 cm.
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g = 2.94 feature is attributed to denatured bis-histidine b-
type and/or c1-type cytochromes [19]. The major differences
are: (1) the g = 3.16 feature resulting from the ascorbate-
reducible Met/His-axially-ligated cytochrome c1 in the wild-
type complex has been replaced by a g = 3.30 feature in the
M183K variant; and (2) the g = 3.44 feature is broader and
has greater relative intensity in the M183K variant than in
wild-type cytochrome c1. The implication of these findings
is that the heme in oxidized M183K cytochrome c1 is low-
spin ferric, and exhibits a broad low-field resonance with a
component near g = 3.30 that underlies the g = 3.44 compo-
nent arising from cytochrome bH.
This interpretation of the EPR spectrum of the M183K
cytochrome c1 in the intact cytochrome bc1 complex is borne
out by the EPR spectrum of purified M183K cytochrome c1,
which exhibits low-field features at g= 3.57, 3.30 and 2.94
(Fig. 2B). On the basis of the EPR studies of purified wild-
type cytochrome c1 from Rb. capsulatus and the EPR results
for the M183H cytochrome c1 discussed below, the g= 2.94
component is attributed to a bis-histidine form of cyto-
chrome c1. By analogy with the EPR spectra of well-
characterized low-spin Fe(III) hemes with His/amine (lysine,
N-terminal amine or exogenous amine) axial ligation [39–
44], the g = 3.57 and 3.30 features in M183K cytochrome c1
are both assigned to species with His/Lys axial ligation.
While the origin of the heterogeneity is unclear, analogous
behavior is the norm rather than the exception in His/amine-
ligated hemes. For example, g = 3.56 and 3.33 species for the
His/Lys-ligated heme in alkaline yeast cytochrome c [40],
g = 3.53 and 3.30 species for the His/Lys-ligated heme in the
Met100Lys variant of Thiobacillus versutus cytochrome c-
550 [44], and g = 3.53 and 3.06 species for the His/N-
terminal amine ligated heme in spinach cytochrome f [42]
have been reported. The relative concentrations of the His/
Lys-and His/His-ligated hemes in the sample of purified
M183K cytochrome c1 used to obtain the spectrum shown in
Fig. 2B were assessed to be 4:1 by comparing the total area
under the g = 3.57 and 3.30 absorption-shaped components
with that under the g = 2.94 absorption-shaped component,
and correcting for the transition probabilities using published
procedures [45]. However, it should be noted that the
percentage of His/Lys-ligated heme was quite variable in
four different preparations, ranging from a high of 80% to a
low of 50%.
Three distinct low-spin Fe(III) heme species are apparent
in the near-IR low-temperature MCD spectrum of the
cytochrome bc1 complex containing the M183K cyto-
chrome c1 variant (Fig. 3A). Each species exhibits two
positive temperature-dependent MCD bands that arise from
porphyrin(k)-to-Fe(III) charge-transfer transitions. The
lower energy band is invariably narrower and more intense,
and provides a convenient marker of charge-transfer energy
and thus of the heme axial ligation [38]. On the basis of the
previous analysis of the near-IR MCD spectrum of intact
cytochrome bc1 complexes [19], the band at 1590 nm and
the pronounced shoulder at 1650 nm in the spectrum of the
cytochrome bc1 complex containing M183K cytochrome c1
are assigned to cytochrome bL and cytochrome bH, respec-
tively. Replacement of Met by Lys as the axial heme ligand
in the cytochrome c1 M183K variant is confirmed by the
absence of 1890-nm band, which is a characteristic of the
His/Met axial ligation in the wild-type complex (Fig. 3A),
and the appearance of a new band at 1500 nm. Confirmation
that this band arises exclusively from cytochrome c1 comes
from the spectrum of the purified M183K cytochrome c1
(Fig. 3B), which shows the spectrum of the component with
the charge-transfer maximum at 1500 nm in isolation.
Although the presence of a heme with bis-His axial ligation
cannot be ruled out based exclusively on the energies of the
near-IR charge-transfer bands (bis-His, 1500–1660 nm;
His/amine, 1480–1550 nm [19,39]), the observation of a
charge-transfer band at 1500 nm in the M183K variant is
clearly consistent with His/Lys axial ligation. Coupled with
the EPR results discussed above and the different near-IR
MCD spectra typical of bis-His forms of the cytochrome c1,
which have charge-transfer bands at 1520 nm (see below),
the near-IR MCD data obtained for M183K cytochrome c1
provide convincing evidence for the presence of His/Lys
axial heme ligation in both the purified protein and the intact
cytochrome bc1 complex.
Fig. 2. X-band EPR spectra of Rb. capsulatus cytochromes. (A) Cytochrome
bc1 complex containing M183K cytochrome c1 (39 AM). (B) Purified
M183K cytochrome c1 (148 AM). (C) Cytochrome bc1 complex containing
M183H cytochrome c1 (29 AM). (D) Purified M183H cytochrome c1 (24
AM). The buffer conditions are: 100 mMTris–DCl (pD= 8.0), 10 mMNaCl,
0.1% dodecyl maltoside and 55% d3-glycerol for (A) and (C); 25 mM Tris–
DCl (pD 8.0), 10 mM NaCl, 0.25% cholate and 55% d2-ethylene glycol
for (B); 25 mM Tris–DCl (pD 8.0), 10 mM NaCl, 1% cholate and 55%
d3-glycerol for (D). All spectra were recorded at 10 K and instrument
settings were: number of scans, 5; microwave power, 10 mW; modulation
amplitude, 1.0 mT; microwave frequency, 9.59 GHz.
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3.2. Spectroscopic properties of the M183H cytochrome c1
variant
The EPR spectrum of the intact cytochrome bc1 complex
containing the M183H cytochrome c1 variant exhibits low-
field features at g = 3.78 and 3.44, corresponding to cyto-
chrome bL and cytochrome bH, respectively, and an intense
low-field feature at g = 2.95 (Fig. 2C). The intensity of the
g = 2.95 feature has more than doubled with respect to
g = 3.78 and 3.44 features, when compared to spectrum of
the wild-type cytochrome bc1 complex, and the g = 3.16
feature associated with Met/His-axially ligated wild-type
cytochrome c1 [19] is no longer observed. This indicates that
the M183H cytochrome c1 is responsible in large part for the
g = 2.94 resonance in the intact complex, and this inference is
confirmed by EPR studies of the purified M183H cyto-
chrome c1, for which the only resonance in the low-field
region is at g = 2.94 (Fig. 2D). Near-IR MCD studies provide
further characterization of the consequences of the M183H
mutation on the properties of cytochrome c1 in both the intact
cytochrome bc1 complex and purified cytochrome c1 (Fig.
3C and D, respectively). In both samples, it is evident that the
M183H cytochrome c1 contributes a charge-transfer band at
1520 nm. These spectroscopic characteristics, i.e., the
‘‘g = 2.94’’ resonance and charge-transfer band at 1520 nm,
are identical to those previously established for wild-type
purified cytochrome c1 from Rb. capsulatus [19]. These
features were attributed to a bis-His form of cytochrome c1
by analogy with the properties of well characterized bis-
imidazole Fe(III) porphyrins, imidazole derivatives of myo-
globin and horse heart cytochrome c, and many bis-histidine
hemoproteins [19]. In wild-type cytochrome c1, the bis-His
species is formed as the result of a protein conformational
change that recruits a histidine ligand when cytochrome bc1
complex is removed from the membrane environment, or
cytochrome c1 is separated from the cytochrome bc1 com-
plex, or from a combination of both procedures [19]. This
replacement of the methionine axial ligand by a recruited
histidine can also be triggered by treatments such as altering
the solvent composition [19]. As only the bis-His form of
cytochrome c1 is present in the intact cytochrome bc1 com-
plex isolated from the M183H variant, it is tempting to
conclude that His183 supplies the sixth ligand in the
M183H variant. Although, the spectroscopic data cannot
discriminate between various forms with different histidines
bound in the sixth position, the oxidation–reduction titra-
tions discussed below suggest that the purified M183H
cytochrome c1 studied in this work is a mixture of species
with the sixth ligand being either His183 or a yet-to-be-
identified histidine residue present in the wild-type cyto-
chrome.
3.3. Oxidation–reduction titrations of the heme center in
various forms of cytochrome c1
Determination of an unambiguous Em value for wild-
type Rb. capsulatus cytochrome c1 in purified cytochrome
bc1 complexes is relatively simple because this value is so
much more positive than the Em values for cytochromes bH
and bL that titrations of the c-type and b-type cytochromes
do not overlap [27]. In contrast, the Em values of Rb.
capsulatus cytochrome c1 variants in which the M183 axial
ligand has been replaced are close enough to those for the
wild-type b cytochromes, that spectral overlaps make it very
difficult to determine precise Em values for the heme of
M183K and M183H cytochrome c1 in these multi-compo-
nent systems [24]. To eliminate these problems, redox
titrations of Rb. capsulatus M183K and M183H cyto-
chrome c1 were carried out using purified samples of
cytochrome c1. Fig. 4 shows the results of these titrations
and also of a titration of purified wild-type cytochrome c1
(note that all samples of cytochrome c1 used for the
titrations shown in Fig. 4 were separated from cytochrome
bc1 complexes in the presence of DTT). There are two
striking features of these titrations: (1) all show multiple Em
components; and (2) in each case, the titration curves
Fig. 3. Near-IR low-temperature MCD spectra of Rb. capsulatus
cytochromes. (A) Cytochrome bc1 complex containing M183K cyto-
chrome c1. (B) Purified M183K cytochrome c1. (C) Cytochrome bc1
complex containing M183H cytochrome c1. (D) Purified M183H
cytochrome c1. The samples were identical to those used for EPR studies
and are described in Fig. 1. All spectra were recorded with an applied
field of 6 T at 1.90 K, and all bands were temperature dependent with
saturation magnetization curves indicative of a S= 1/2 ground state.
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obtained in the oxidative direction differ from those ob-
tained in the reductive direction.
Reductive titrations of purified wild-type Rb. capsulatus
cytochrome c1 (Fig. 4A) indicate the presence of three
components, with Em values, respectively, of + 275 mV
(accounting for approximately 50% of the total amplitude),
+ 75 mV (approximately 15% of the total amplitude) and
 115 mV (approximately 35% of the total amplitude). The
Em= + 275 mV value for the high-potential component
obtained from titrations of the purified wild-type cyto-
chrome c1 is somewhat lower than that obtained in this
study for cytochrome c1 within the intact cytochrome bc1
complex and the two-subunit subcomplex lacking the
Rieske protein (see Fig. 5). However, this Em=+ 275 mV
value agrees, within the experimental uncertainties in the
measurements, with values at the lower end of the range of
Em’s reported for the cytochrome c1 component of the intact
cytochrome bc1 complex [27]. Therefore, this component is
attributed to cytochrome c1 with His/Met axial ligation.
Oxidative titrations of the purified wild-type cytochrome
show considerable differences from those performed in the
reductive direction (Fig. 4A). No Em= + 275 mV component
was detected in the oxidative titrations, but instead two
components, with Em values of + 165 mV (accounting for
approximately 25% of the total amplitude) and  120 mV
(accounting for approximately 75% of the total amplitude),
respectively, were found. Fig. 5 shows that redox titrations
(over the Eh range from + 450 to + 180 mV) of the heme of
wild-type cytochrome c1, either in the intact cytochrome bc1
complex (Fig. 5A) or in the two-subunit subcomplex miss-
ing the Rieske protein (Fig. 5B), were identical, regardless
of whether they were carried out in the oxidative or the
reductive direction. Only a single high-potential component,
with an Em of approximately + 325 mV, was detected in
these titrations. This Em value is in good agreement for that
obtained in recently published titrations of wild-type cyto-
chrome c1 in the intact cytochrome bc1 complex [25,46].
Spectral changes arising from cytochromes bH, bL, and from
a third form of cytochrome b, b150 [24,47], made it difficult
to completely rule out the possibility that small amounts of
lower-potential forms of cytochrome c1 might be present in
these two preparations. Despite this uncertainty, the differ-
ences between the titrations shown in Fig. 4A and those
shown in Fig. 5A and B suggest that the redox heterogeneity
and the lack of reversibility seen in the titrations of purified
wild-type cytochrome c1 do not appear to be intrinsic
properties of cytochrome c1 in the native environment found
in the intact cytochrome bc1 complex. Furthermore, the
observation that redox titrations of cytochrome c1 carried
out with the intact cytochrome bc1 complex and with the
two-component subcomplex are essentially identical, allows
one to conclude that the lack of reversibility observed in
titrations of isolated cytochrome c1 does not arise from
removing interactions between cytochrome c1 and the
Rieske protein.
In reductive titrations of both the M183K (Fig. 4B) and
M183H (Fig. 4C) variants, no high-potential component was
observed. These titrations revealed the presence of both a
minor (approximately 17% of the total amplitude for M183K
and 8% for M183H) intermediate-potential form (Em= + 60
mV for M183K and Em= + 35 mV for M183H) and a major
(approximately 85% of the total amplitude for M183K and
90% for M183H) low-potential form (Em = 130 mV for
M183K and Em = 135mV forM183H). As was the case for
the titrations of purified wild-type cytochrome c1, the results
of titrations of the M183K and M183H variants performed in
the oxidative direction were not identical to those obtained
from reductive titrations. In the case of both the M183K
variant (Fig. 4B) and the M183H variant (Fig. 4C), only a
single low-potential component was observed in oxidative
titrations with Em values of  130 and  145 mV, respec-
tively. Reductive titrations, following an initial reductive/
oxidative titration cycle, again revealed the presence of the
high-potential form of the isolated wild-type cytochrome c1
Fig. 4. Oxidation– reduction titrations of wild-type Rb. capsulatus cytochrome c1 and its M183H and M183K variants. All titrations were carried out using the
following buffer: 50 mM MOPS (pH 7.0) containing 100 mM KCl and 0.25% cholate. (A) Wild-type cytochrome c1, at a concentration of 8.6 AM. The closed
circles represent the results of a reductive titration, with the solid line representing the best fit to the Nernst Equation for three n= 1 components. The open
circles represent the results of an oxidative titration, with the solid line representing the best fit to the Nernst equation for two n= 1 components. The Y-axis
represents the relative absorbance at 550 nm minus 540 nm. (B) M183K cytochrome c1, at a concentration of 2.6 AM. (C) M183H cytochrome c1, at a
concentration of 2.3 AM. The symbols and data processing in (B) and (C) are similar to that described in (A).
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and the intermediate-potential form of the M183K variant
(data not shown). Hence, the redox-induced changes are at
least partially reversible in the wild-type and M183K variant.
It has recently been demonstrated that Rb. capsulatus
cytochrome c1, unlike mitochondrial cytochrome c1, con-
tains a disulfide bond [25]. This disulfide, formed by Cys144
and Cys167 and located in an 18-amino-acid loop present in
some bacterial cytochromes c1 but absent in the cyto-
chromes c1 from higher organisms, was estimated to have
an Em value below  300 mV at pH 8.0 and was shown to
be reduced by DTT [25]. Elimination of the disulfide in Rb.
capsulatus cytochrome c1 by site-directed mutagenesis was
shown to produce large changes in the Em value of the
cytochrome’s heme, i.e., from + 320 mV to a value below 0
mV [25]. A series of experiments were designed to inves-
tigate whether the disulfide affected the heme redox hetero-
geneity and the differences observed between oxidative and
reductive titrations of the wild-type cytochrome c1 described
above. Fig. 5C shows the results of redox titrations of the
heme in a sample of cytochrome c1, purified from the intact
cytochrome bc1 complex but, in contrast to the material used
for the titration shown in Fig. 4A, with DTT omitted from
the purification buffers. As is the case in the titration carried
out with protein purified in the presence of DTT (Fig. 4A),
three Em components (Em= + 285 mV, accounting for 66%
of the total absorbance change; Em= + 78 mV, accounting for
13% of the total absorbance change; and Em = 94 mV,
accounting for 21% of the total absorbance change) can be
observed in reductive titrations of wild-type cytochrome c1
prepared in the absence of DTT (Fig. 5C). However, in
contrast to the results observed with wild-type cytochrome
prepared in the presence of DTT (Fig. 4A), oxidative
titrations of the heme of wild-type cytochrome c1 prepared
in the absence of DTT were essentially identical to those
carried out in the reductive direction in the Eh range > + 200
mV (Fig. 5C). These oxidative titrations show a consider-
able amount (accounting for 63% of the total absorbance
change) of a high-potential (Em= + 291 mV) component
(two additional components, with Em= + 160 mV and
 130 mV account for 15% and 22%, respectively, of the
total absorbance change).
The differences observed between the oxidative heme
titrations of Figs. 4A and 5C may have been caused by the
presence of DTT in the buffers used for the redox titrations
or, alternatively, may have resulted from the presence of
DTT in the buffers used to separate cytochrome c1 from the
cytochrome bc1 complex. In an attempt to distinguish
between these two possibilities, a series of redox titrations
were carried out using cytochrome c1 prepared in the
absence of DTT, but with DTT either present or absent
during the redox titrations. The redox properties of cyto-
chrome c1 in the two-subunit subcomplex appear to be
identical to those of the cytochrome in the intact cytochrome
bc1 complex (Fig. 5 and Refs. [28,29]). Thus, all samples of
cytochrome c1 used for these measurements were prepared,
with DTT omitted from the purification buffers, from the
subcomplex because of the higher yields and greater purity
that result from using it as the starting material. For titrations
carried out in the presence of DTT, the DTT was added, at a
concentration of 1 mM, to the cytochrome 18 h prior to the
titration. Regardless of whether the titrations were carried
out in the absence or presence of DTT, high-potential
(Em= + 250, accounting for approximately 50% of the total
absorbance change, in the absence of DTT, and + 260 mV,
Fig. 5. Oxidation– reduction titrations of wild-type Rb. capsulatus
cytochrome c1 in the intact cytochrome bc1 complex, the two-subunit
subcomplex and the isolated cytochrome c1. (A) Intact cytochrome bc1
complex (2.3 AM). (B) Two-subunit subcomplex (2.2 AM). (C) The isolated
cytochrome c1 (6.2 AM), prepared and titrated in the absence of DTT. All
titrations were carried out using the following buffer: 50 mM MOPS (pH
7.0) containing 100 mM KCl and 0.01% n-dodecyl-h-D-maltoside. The
redox mediators are listed in Materials and methods. The open circles
represent the results of oxidative titrations and the closed circles represent
the results of reductive titrations. In all cases, the solid lines represent the
best fit to the Nernst equation for one n= 1 or n= 3 components. The Y-axis
represents the relative absorbance at 550 nm minus 540 nm.
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accounting for slightly more than 50% of the total absorb-
ance change, in the presence of DTT) and low-potential
(Em = 130 mV, accounting for approximately 25% of the
total absorbance change, in the absence of DTT, or  140
mV, accounting for approximately 35% of the total absorb-
ance change, in the presence of DTT) components were
present in both oxidative and reductive titrations. The most
significant differences between the two sets of titrations are
in the amount and Em value for the minor mid-potential
form of the cytochrome (accounting for 15–25% of the total
absorbance change, data not shown). The results of these
titrations suggest that the presence of DTT during the
separation of cytochrome c1 from the cytochrome bc1
contributes significantly to the irreversibility of the heme
titrations shown in Fig. 4A.
3.4. Redox titration of the disulfide bond of cytochrome c1
Although an estimate of a value more negative than
 300 mV was previously made for the Em of the disulfide
bond in Rb. capsulatus cytochrome c1, no exact Em value
was determined in this earlier study [25]. The observation
that the presence of DTT, a reagent known to reduce this
disulfide, affects the redox properties of the heme of
cytochrome c1 (see above) made it of interest to accurately
determine the Em value of this disulfide. Fig. 6 shows an
oxidation–reduction titration of this disulfide in the two-
subunit cytochrome bc1 subcomplex, using the thiol-spe-
cific, fluorescent reagent monobromobimane (mBBr) to
monitor the presence of cysteine thiols at different Eh
values. As the original estimate for the Em of the disulfide
was obtained using samples buffered at pH 8.0 [25], our
initial determinations were also carried out at this pH and an
average Em value of  389F 11 mV (seven determinations)
was measured at this pH (Fig. 6A). As all of the redox
titrations of the cytochrome c1 heme in this study were
carried out at pH 7.0, the disulfide was also titrated at this
pH and a value of  333 mVobtained for the Em at this pH
(Fig. 6B). The 56 mV difference in Em values measured at
the two pH values is close to the 59 mV theoretical value for
a reaction in which a two-electron reduction is accompanied
by the uptake of two protons [35,36], and so we conclude
that the reduction of the disulfide bond in cytochrome c1
results in the uptake of two protons from the medium by the
protein.
Although we have not previously used the mBBr tech-
nique to measure the Em values of disulfide/dithiol couples
in detergent-solubilized, membrane-associated proteins, we
have used it extensively for successful redox titrations of
disulfide/dithiol couples in a large number of soluble
proteins [35,36,50–52] and for a membrane-associated
protein that had been rendered soluble by truncating it so
as to remove its membrane-anchoring domain [53]. Never-
theless, it seemed wise to carry out a control that would
confirm that the data of Fig. 6 do arise from the titration of
the cytochrome c1 disulfide. For that purpose, we have
carried out a titration, similar to those shown in Fig. 6, but
using a two-subunit subcomplex containing the C144A/
C167A double mutation in cytochrome c1 that eliminates
the disulfide [25]. This titration showed mBBr fluorescence
levels that were independent of Eh (data not shown),
confirming that the titrations of Fig. 6 do indeed reflect
the redox properties of the disulfide. As another control, we
have also titrated the heme of cytochrome c1 in the two-
subunit subcomplex containing the C144A/C167A double
mutation in cytochrome c1 and obtained an Em value of
 75 mV (data not shown), a value identical to that
obtained from titrations of the cytochrome c1 heme carried
out using the intact cytochrome bc1 complex with the same
C144A/C167A double mutation in the cytochrome c1
subunit. [25].
4. Discussion
Previous investigations of a M183L variant of Rb. capsu-
latus cytochrome c1 demonstrated that replacement of the
Fig. 6. Oxidation– reduction titrations of the Cys144/Cys167 disulfide of
cytochrome c1. Fluorescence at 473 nm of mBBr-derivatized protein was
measured (excitation at 380 nm) using 500 Ag of the two-subunit
subcomplex, which had been incubated in 100 mM buffer containing
0.01% n-dodecyl-h-D-maltoside. The data were fitted to the Nernst
Equation for a two-electron process. (A) The samples were incubated in
Tricine buffer (pH 8.0), containing DTT at a total concentration of 2.5 mM
(different Eh values were obtained by varying the ratio of reduced/oxidized
DTT), for 2.5 h prior to mBBr-derivitization. (B) The samples were
incubated in MOPS buffer (pH 7.0), containing DTT at a total concentration
of 5.0 mM, for 2.0 h prior to mBBr-derivatization.
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axial methionine ligand by a non-liganding amino acid
triggers a conformational change, in which a portion of
the polypeptide backbone of the protein refolds so that a
substitute axial ligand is recruited to replace Met183
[19,23]. EPR and near-IR MCD measurements suggested
that the recruited ligand was probably a histidine [19].
Molecular modeling studies indicated that either a lysine or
a histidine, placed at position 183 by site-directed muta-
genesis, could function as a replacement axial ligand for
M183 [24]. Thus, it appeared likely that spectroscopic
comparisons of the M183K and M183H variants of cyto-
chrome c1 to the wild-type cytochrome and its M183L
variant could be used to establish that a histidine residue,
rather than lysine, was indeed the recruited ligand. The fact
that the EPR and near-IR MCD spectra of the M183L and
M183H variants of Rb. capsulatus cytochrome c1, obtained
in the current study, resemble each other so closely and the
fact that they differ from those of the M183K variant
provide new strong evidence that the recruited ligand is
indeed a histidine.
The earlier studies showed that wild-type cytochrome c1,
particularly when removed from its natural environment as
part of the membrane-associated cytochrome bc1 complex,
can also undergo a conformational change that results in the
replacement of Met183 as an axial ligand [19]. Comparison
of the EPR and near-IR MCD spectra of this form of the
wild-type Rb. capsulatus cytochrome c1 [19] to those
obtained for the M183K and M183H forms of the same
cytochrome, leaves little doubt that the recruited ligand in
this case is also a histidine, resulting in a bis-His-ligated
heme. The EPR and near-IR MCD properties of the M183K
cytochrome c1, both in the purified protein and the intact bc1
complex, provide convincing evidence for a His/Lys ligated
heme. However, once removed from its natural environ-
ment, the EPR spectrum of the purified M183K cytochrome
c1 again shows that a histidine can also partially displace the
lysine, to give a heme with bis-His ligation, instead of His/
Lys ligation.
As the EPR and near-IR MCD spectroscopic techniques
used in this study cannot distinguish one His/His-ligated
cytochrome c1 from another, it is not possible to determine
whether the His/His ligation seen for the M183H variant
utilizes only the histidine inserted at position 183 by site-
directed mutagenesis as an axial ligand, or contains exclu-
sively the recruited histidine as a ligand, or is a mixture of
species with different histidine ligands. The asymmetric
Soret band seen for the reduced form of the M183H variant
and the presence of two Em components in redox titrations
of this variant are consistent with heterogeneity at the heme
center. In any event, it is clear that the form in which one of
the three additional histidines present outside the CSACH
heme-binding domain of Rb. capsulatus cytochrome c1
serves as an axial ligand has substantial thermodynamic
stability. Identification of the specific histidine(s) that can
serve as a recruited heme ligand will require additional site-
directed mutagenesis studies. These observations are con-
sistent with the proposal that a bis-histidyl form of Rb.
capsulatus cytochrome c1 may be a folding intermediate
during the formation of the native conformation [24], as has
been shown in the case of mitochondrial cytochrome c
[48,49].
Previous redox titrations of purified cytochrome bc1
complexes containing M183K and M183H forms of Rb.
capsulatus cytochrome c1 suggested the presence of heme c
species with Em7 values near + 60 mV and + 35 mV for the
M183K and M183H variants, respectively [24]. Redox titra-
tions performed on isolated cytochrome c1, as part of the
current study, confirmed the presence of heme species with
similar Em7 values (Fig. 4B and C). These earlier titrations
also suggested the possibility that additional, lower-potential
cytochrome c1 components might be present, but spectral
overlap with cytochrome b made it impossible to establish
this with certainty [24]. The titrations carried out in this study
now provide clear evidence for the presence of such a low-
potential component (Em7 = ca.  130 mV) in both M183K
and M183H cytochrome c1. Fig. 4A shows that an inter-
mediate-potential form (Em7= + 75 mV) and a low-potential
form (Em7 = 115 mV) can be observed in titrations of the
purified wild-type cytochrome, in addition to the Em7= + 275
mV component, a value that can be assigned to the wild-type,
His/Met-ligated form of cytochrome c1.
The identity of the intermediate and low potential redox
components in the wild-type and variant forms of purified
cytochrome c1 can be inferred by combining the spectro-
scopic and redox data. As the midpoint potentials of the
lowest potential forms are similar in the wild-type cyto-
chrome and in the M183H and M183K variants, this sug-
gests the possibility that the chemical nature of the lowest
potential form may be identical in all three cases. Taken as a
whole, the data presented above make it likely that the lowest
potential form (i.e., Em= ca.  130 mV) is a bis-His form of
cytochrome c1 involving the recruited histidine, as spectro-
scopic studies indicate that this is the only species that is
common to purified samples of wild-type cytochrome c1 and
both variants. The intermediate potential species observed
during reductive redox titrations of the M183K and M183H
variants, Em= + 60 mV and + 35 mV, respectively, are there-
fore assigned to His/Lys (for M183K) and His/His (for
M183H) forms involving the residue at position 183. The
discrepancy between the ratio of His/His and His/Lys forms
as estimated by EPR (in the range 20:80 to 50:50) and redox
titrations (ca. 85:15) could well be a consequence of the
different conditions under which the measurements were
carried out, i.e., using liquid He-temperature frozen solution
to obtain EPR spectra and room-temperature aqueous sol-
utions for the redox titrations. The origin of the intermediate
potential species observed in redox titrations of wild-type
cytochrome c1 is more enigmatic. Our observation, as part of
this study, that wild-type cytochrome c1, but not the M183K
and M183H variants, exhibits a significant, but variable
intensity, high-spin EPR signal in the g = 6 region (data not
shown), suggests that the possibility that the intermediate-
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potential form could be a high-spin form with His/H2O axial
ligation. However, the fact that alpha-band difference spectra
in this Eh region are similar to those observed at higher and
lower potentials argues against such an interpretation. If,
however, there is a high-spin form of cytochrome c1,
analogies to cytochrome c [48,49] suggest that the high-spin
form, in addition to the bis-His form discussed above, could
well be a folding intermediate.
Comparisons of reductive titrations of purified cyto-
chrome c1, isolated in the presence of DTT, with oxidative
titrations of the same protein show clear differences
between titrations carried out in different directions. This
is in contrast to the situation observed for the intact, native
cytochrome bc1 complex, or for the two sub-unit subcom-
plex, where titrations carried out in both directions are
identical. The nature of the event(s) that causes these large
differences between reductive and oxidative redox titra-
tions when Rb. capsulatus cytochrome c1 is removed from
the cytochrome bc1 complex is not completely clear.
However, as titrations of cytochrome c1 in the two-subunit
subcomplex show the same properties as those carried out
with the intact complex, these differences in redox behav-
ior are unlikely to involve interactions between the Rieske
protein and cytochrome c1. One possibility is that the
differences between the oxidative and reductive titrations
are linked to conformational changes, triggered by the
change in the oxidation state of the heme of cytochrome
c1, which can occur in the isolated cytochrome but not in
the intact complex. An alternative possibility is that the use
of DTT during purification may cause changes in the
redox state of the recently discovered disulfide in Rb.
capsulatus cytochrome c1 [25]. These changes in the redox
state of the disulfide may trigger conformational changes
that, in turn, produce the ligand switching and redox
titration phenomena observed in this study. The previously
reported observation [25] that removing this disulfide has a
dramatic effect on the Em value of the cytochrome c1
heme, and the effects of DTT on the redox properties of
this heme reported above, are consistent with this possi-
bility. The much lower propensity for axial ligand con-
formational flexibility for mitochondrial cytochrome c1,
observed in our earlier studies [19], could then be ration-
alized in terms of the absence of a disulfide in the
crystallographically defined mitochondrial cytochrome c1
[20–22,54].
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